3516
  Mrv0541 02231216592D          

 10 10  0  0  0  0            999 V2000
    2.8075   -0.9034    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6655   -0.9034    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2365   -0.9034    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9509    0.3341    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220    0.3341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220   -0.4909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2365    0.7466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9509   -0.4909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075    0.7466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0930    1.1592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  6  2  0  0  0  0
  2  8  2  0  0  0  0
  3  6  1  0  0  0  0
  3  8  1  0  0  0  0
  4  7  1  0  0  0  0
  4  8  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  2  0  0  0  0
  5  9  1  0  0  0  0
  9 10  3  0  0  0  0
M  END
> <DRUGBANK_ID>
DB03516

> <DRUG_GROUPS>
investigational

> <GENERIC_NAME>
Eniluracil

> <SYNONYMS>


> <CHEMICAL_FORMULA>
C6H4N2O2

> <MOLECULAR_WEIGHT>
136.1082

> <EXACT_MASS>
136.027277382

> <IUPAC_NAME>
5-ethynyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

> <IUPAC_TRADITIONAL_NAME>
5-ethynyl-1,3-dihydropyrimidine-2,4-dione

> <INCHI_IDENTIFIER>
InChI=1S/C6H4N2O2/c1-2-4-3-7-6(10)8-5(4)9/h1,3H,(H2,7,8,9,10)

> <INCHI_KEY>
InChIKey=JOZGNYDSEBIJDH-UHFFFAOYSA-N

> <SMILES>
O=C1NC=C(C#C)C(=O)N1

> <JCHEM_ACCEPTOR_COUNT>
2

> <JCHEM_DONOR_COUNT>
2

> <JCHEM_ACIDIC_PKA>
9.5

> <JCHEM_BASIC_PKA>
-6.4

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <ALOGPS_LOGP>
-0.91

> <JCHEM_LOGP>
-0.82

> <ALOGPS_LOGS>
-2.7

> <JCHEM_POLARIZABILITY>
12.05

> <JCHEM_POLAR_SURFACE_AREA>
58.2

> <JCHEM_REFRACTIVITY>
33.39

> <JCHEM_ROTATABLE_BOND_COUNT>
0

> <ALOGPS_SOLUBILITY>
2.54e-01 g/l __ 

$$$$
